demonstrated that ATRA inhibits tumour growth in ESCC and enhances the responsiveness of ESCC tumours to anti‐PD‐1 immunotherapy by promoting the translation of OTUD6B. Here, OTUD6B is linked to esophageal squamous cell carcinoma.